Identification of People Infected With Hepatitis C Virus Who Have Never Been Diagnosed.
作者信息
Kowdley Kris V
机构信息
Director, Liver Institute Northwest Clinical Professor, Elson S. Floyd College of Medicine Washington State University Seattle, Washington.
出版信息
Gastroenterol Hepatol (N Y). 2019 Dec;15(12):669-671.
Abstract
摘要
相似文献
1
Identification of People Infected With Hepatitis C Virus Who Have Never Been Diagnosed.
Gastroenterol Hepatol (N Y). 2019 Dec;15(12):669-671.
2
Identification of a novel variant of hepatitis E virus in Italy.
J Med Virol. 1999 Apr;57(4):356-60. doi: 10.1002/(sici)1096-9071(199904)57:4<356::aid-jmv5>3.0.co;2-d.
3
Detection and analysis of hepatitis C virus in HIV-infected patients in the Guangxi province of China.
Exp Ther Med. 2017 Mar;13(3):917-923. doi: 10.3892/etm.2017.4067. Epub 2017 Jan 20.
4
Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus.
J Infect Dis. 2001 Aug 1;184(3):359-63. doi: 10.1086/322020. Epub 2001 Jun 26.
5
HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar.
BMC Public Health. 2017 Nov 28;17(1):917. doi: 10.1186/s12889-017-4933-0.
6
Cross-sectional epidemiology of hepatitis C virus detection and treatment in HIV-infected patients.
Eur J Intern Med. 2011 Feb;22(1):66-72. doi: 10.1016/j.ejim.2010.08.006. Epub 2010 Sep 15.
7
Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada.
World J Gastroenterol. 2018 Mar 21;24(11):1216-1227. doi: 10.3748/wjg.v24.i11.1216.
8
Prevalence of hepatitis B and C in pregnant women who are infected with human immunodeficiency virus.
Am J Obstet Gynecol. 2005 Sep;193(3 Pt 2):1270-3. doi: 10.1016/j.ajog.2005.07.002.
9
Hepatitis B and C Virus Infections Among Human Immunodeficiency Virus-Infected People Who Inject Drugs in Lahore, Pakistan.
Viral Immunol. 2017 Jun;30(5):366-370. doi: 10.1089/vim.2016.0144. Epub 2017 Mar 27.
10
Initial uptake, time to treatment, and real-world effectiveness of all-oral direct-acting antivirals for hepatitis C virus infection in the United States: A retrospective cohort analysis.
PLoS One. 2019 Aug 22;14(8):e0218759. doi: 10.1371/journal.pone.0218759. eCollection 2019.
引用本文的文献
1
Assessing user experience with the Bioline™ HCV point-of-care test in primary healthcare settings: a mixed-methods study.
BMC Health Serv Res. 2025 Apr 1;25(1):484. doi: 10.1186/s12913-025-12634-8.
2
REASSURED evaluation of the Bioline HCV point-of-care testing for diagnosing hepatitis C virus infection in primary healthcare settings of Ghana: a study protocol.
BMJ Open. 2024 Nov 9;14(11):e082416. doi: 10.1136/bmjopen-2023-082416.
3
Seroprevalence of Hepatitis C Virus and Factors Associated with It in Armenia, 2021.
Viruses. 2024 Sep 11;16(9):1446. doi: 10.3390/v16091446.
4
Quality Assurance for Hepatitis C Virus Point-of-Care Diagnostics in Sub-Saharan Africa.
Diagnostics (Basel). 2023 Feb 12;13(4):684. doi: 10.3390/diagnostics13040684.
本文引用的文献
1
Prevalence of Hepatitis C Virus Infection in US States and the District of Columbia, 2013 to 2016.
JAMA Netw Open. 2018 Dec 7;1(8):e186371. doi: 10.1001/jamanetworkopen.2018.6371.
2
Cost Effectiveness of Universal Screening for Hepatitis C Virus Infection in the Era of Direct-Acting, Pangenotypic Treatment Regimens.
Clin Gastroenterol Hepatol. 2019 Apr;17(5):930-939.e9. doi: 10.1016/j.cgh.2018.08.080. Epub 2018 Sep 8.
3
Prevalence of Diagnosed and Undiagnosed Hepatitis C in a Midwestern Urban Emergency Department.
Clin Infect Dis. 2016 May 1;62(9):1066-71. doi: 10.1093/cid/ciw073. Epub 2016 Feb 21.
4
Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012.
MMWR Morb Mortal Wkly Rep. 2015 May 8;64(17):453-8.
5
Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.
Clin Infect Dis. 2014 Nov 15;59(10):1411-9. doi: 10.1093/cid/ciu643. Epub 2014 Aug 11.
Zotero 插件